THE RED DIAMOND AMONGST ANTIOXIDANTS
LIVE

Serial Number

79341321

Owner

BDI Holding GmbH

Attorney

Sheryl De Luca

Filing Date

May 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

THE RED DIAMOND AMONGST ANTIOXIDANTS Trademark

Serial Number: 79341321 • Registration: 7282210

THE RED DIAMOND AMONGST ANTIOXIDANTS is a trademark filed by BDI Holding GmbH on May 3, 2022. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BDI Holding GmbH (3 trademarks)

Parkring 18

Entity Type: 27

Trademark Details

Filing Date

May 3, 2022

Registration Date

January 23, 2024

Published for Opposition

November 7, 2023

Goods & Services

Moustache wax; skin cream; cosmetic dyes, for hair, skin, and lips; greases for cosmetic purposes; dental bleaching gels; flavourings for beverages being essential oils; cosmetic creams; cosmetic preparations for skin care; cosmetics; cosmetics for animals; cosmetic kits comprised of body lotion, lip salves, hand cream, cosmetic skin care preparations for the day, cosmetic skin care preparations for the night; cosmetic pencils; lip glosses; lipsticks; make-up; beauty masks; ethereal oils; oils for toilet purposes; oils for cosmetic purposes; perfumery, essential oils; powder for make-up; oils for cleaning purposes; make-up preparations; make-up powder; non-medicated toiletry preparations; beauty care cosmetics; sunscreen preparations; sun-tanning preparations; deodorant soap; body soap, toilet soap, non-medicated soap; shampoos; shampoos for pets; cakes of toilet soap

Seaweeds for use as a fertilizer; industrial chemicals; chemicals used in science; chemical additives for oils; esters; enzyme preparations for the food industry; ferments for chemical purposes, namely, for use in the manufacture of cosmetics, food supplements and pet food; oils for the preservation of food; chemical substances for preserving foodstuffs; preservatives for pharmaceutical preparations; chemicals for use in agriculture, except fungicides, herbicides, insecticides and parasiticides

Medicines for human purposes, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; medicines for veterinary purposes, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; therapeutic medicated preparations for the bath; bacterial preparations for medical and veterinary use; chemical preparations for medical purposes, namely, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; chemical preparations for pharmaceutical purposes, namely, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; chemical preparations for veterinary purposes, namely, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; chemico-pharmaceutical preparations, namely, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; carotinoid esters for pharmaceutical purposes; greases for medical purposes; greases for veterinary purposes; dietetic beverages for babies adapted for medical purposes; medicinal drinks; pharmaceutical preparations for skin care; capsules sold empty for medicines; chewing gum for medical purposes; cultures of microorganisms for medical or veterinary use; nutritional supplements; dietary supplements for animals; dietetic foods adapted for medical purposes; medicinal oils; pharmaceutical preparations, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; ointments for pharmaceutical purposes, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; pharmaceutical preparations for treating sunburn; veterinary preparations, for the treatment of inflammation, cells unhealthiness, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cancer diseases, immune deficiency, infertility, muscle weakness, eye fatigue, Heliobacter infection; vitamin preparations

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 15, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 15, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 15, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 13, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 24, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 24, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 23, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 21, 2023 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 7, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 6, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 1, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 1, 2023 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 18, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 18, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2023 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 12, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 28, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 14, 2023 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 17, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 17, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 4, 2023 PBCR
EXAMINERS AMENDMENT MAILED
Jun 22, 2023 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 22, 2023 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2023 TROA
REFUSAL PROCESSED BY IB
May 10, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 18, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Feb 27, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 31, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 26, 2022 REPR